WESTPORT, Conn., March 10, 2014 /PRNewswire/ -- TriStar Wellness Solutions(R), Inc. (OTCQB: TWSI), a health and wellness company that targets opportunities in the self-care and professional marketplace, announced today that its wholly owned subsidiary HemCon Medical Technologies, Inc. has instituted a growth plan for European expansion.
Logo - http://photos.prnewswire.com/prnh/20140310/PH79886LOGO-a
Logo - http://photos.prnewswire.com/prnh/20140310/PH79886LOGO-b
HemCon's main focus over the last 6 months has been to solidify the North American acute care hospital market. Having established a very experienced professional North America sales force, the company is now able to expand its reach and efforts into the European wound care market, a rapidly growing market estimated at over $6.8 billion[i].
HemCon currently has a strong distributor network in place, which has built a solid foundation and allows the European business to grow at the current annual rate of 50%. This dramatic growth is led by distributors within the U.K., the Netherlands, Switzerland, Austria, Turkey, Denmark and Italy, with many other partners in multiple countries now looking to expand HemCon's footprint.
In an effort to capitalize on this momentum HemCon will attend EuroPCR in Paris, France on May 20-23, 2014, EuroPCR is a leading cardiovascular-focused congress which attracts a global community of leading medical professionals and business partners and brings focus to one of HemCon's key markets.
"This conference gives HemCon the opportunity to meet with current and future distributors from around the world," said Simona Buergi, HemCon's Director of Marketing. "This will allow us to gather crucial feedback on European market dynamics and plot a successful trajectory towards multinational growth."
About HemCon Medical Technologies
HemCon Medical Technologies Inc., founded in 2001, develops, manufactures, and markets innovative technologies for hemostatic devices for the control of bleeding resulting from trauma or surgery. HemCon products are designed for use by military and civilian first responders as well as medical professionals in hospital and clinical settings where control of bleeding is of critical importance. HemCon is headquartered in Portland, Ore. With a 36,000 sq. ft. state-of-the-art manufacturing facility, the Company has additional commercial operations in Ireland and the Czech Republic. For more information, please visit www.hemcon.com.
About TriStar Wellness Solutions
TriStar Wellness Solutions®, Inc. (TWSI) is a health and wellness company that targets under-met consumer opportunities in the OTC and professional marketplace. Its core strategy plans to meet the growing demand for personalized care solutions by leveraging proprietary innovation and healthcare technology with the rapid transformation of the healthcare marketplace to create innovative, science-based solutions and brands. TriStar recently acquired HemCon Medical Technologies Inc., a developer, manufacturer, and marketer of innovative technologies for hemostatic devices for the control of bleeding resulting from trauma or surgery. It also owns the Beaute de Maman™ brand of women's health products. Additional information is available at www.tstarwellness.com.
Forward-Looking Statement
This press release for TriStar Wellness Solutions®, Inc. contains forward-looking statements. Generally, you can identify these statements because they use words like "anticipates," "believes," "expects," "future," "intends," "plans," and similar terms. These statements reflect only our current expectations. Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy and actual results may differ materially from those we anticipated due to a number of uncertainties, many of which are unforeseen, including, among others, the risks we face as described our filings with the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements which apply only as of the date of this press release. To the extent that such statements are not recitations of historical fact, such statements constitute forward-looking statements that, by definition, involve risks and uncertainties. In any forward-looking statement where we express an expectation or belief as to future results or events, such expectation or belief is expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the statement of expectation of belief will be accomplished.
SOURCE: TriStar Wellness Solutions®, Inc.
Contact:
Simona Buergi
Tel: (503) 245-0459
[email protected]
SOURCE TriStar Wellness Solutions
/Web site: http://www.tstarwellness.com
[i] Worldwide Wound Care Market. June 2012. Kalorama Information
SOURCE TriStar Wellness Solutions, Inc.
Share this article